
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999.SZFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
3,866
Cost of Revenue
1,881
Gross Profit
1,986
Gross Margin
51.4%
Operating Income
627
Operating Margin
16.2%
Net Income
472
Net Margin
12.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
676
EBITDA Margin
17.5%
2023
12/31/2023
Revenue
3,463
Cost of Revenue
1,634
Gross Profit
1,829
Gross Margin
52.8%
Operating Income
525
Operating Margin
15.2%
Net Income
399
Net Margin
11.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
592
EBITDA Margin
17.1%
2022
12/31/2022
Revenue
2,531
Cost of Revenue
1,170
Gross Profit
1,362
Gross Margin
53.8%
Operating Income
413
Operating Margin
16.3%
Net Income
343
Net Margin
13.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
455
EBITDA Margin
18.0%
2021
12/31/2021
Revenue
2,176
Cost of Revenue
918
Gross Profit
1,258
Gross Margin
57.8%
Operating Income
346
Operating Margin
15.9%
Net Income
288
Net Margin
13.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
370
EBITDA Margin
17.0%
2020
12/31/2020
Revenue
1,909
Cost of Revenue
720
Gross Profit
1,189
Gross Margin
62.3%
Operating Income
290
Operating Margin
15.2%
Net Income
224
Net Margin
11.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
320
EBITDA Margin
16.7%